Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study

被引:24
|
作者
Yin, Shi-Wei [1 ]
Zhou, Zheng [1 ]
Wang, Jun-Ling [2 ]
Deng, Yun-Feng [2 ]
Jing, Hui [1 ]
Qiu, Yi [3 ]
机构
[1] Shandong Univ, Shandong Prov Publ Hlth Clin Ctr, Katharine Hsu Int Res Inst Infect Dis, Affiliated Hosp, Jinan 250013, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Publ Hlth Clin Ctr, Dept Clin Lab, Affiliated Hosp, Jinan 250013, Shandong, Peoples R China
[3] Maternal & Child Hlth Care Hosp Shandong Prov, Key Lab Birth Regulat & Control Technol, Natl Hlth Commiss China, 238 East Rd Jingshi, Jinan 250014, Shandong, Peoples R China
关键词
Asymptomatic; COVID-19; Interleukin; Lymphocyte subset; SARS-CoV-2; Viral load; CORONAVIRUS DISEASE 2019; CLINICAL CHARACTERISTICS; PERIPHERAL-BLOOD;
D O I
10.1186/s12985-021-01597-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Tens of million cases of coronavirus disease-2019 (COVID-19) have occurred globally. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attacks the respiratory system, causing pneumonia and lymphopenia in infected individuals. The aim of the present study is to investigate the laboratory characteristics of the viral load, lymphocyte subset and cytokines in asymptomatic individuals with SARS-CoV-2 infection in comparison with those in symptomatic patients with COVID-19. Methods From January 24, 2020, to April 11, 2020, 48 consecutive subjects were enrolled in this study. Viral loads were detected by RT-PCR from throat-swab, sputum and feces samples. Lymphocyte subset levels of CD3 + , CD4 + , and CD8 + T lymphocytes, B cells and NK cells were determined with biological microscope and flow cytometric analysis. Plasma cytokines (IL2, IL4, IL5, IL6, IL8, IL10, TNF-alpha, IFN-alpha and IFN-gamma) were detected using flow cytometer. Analysis of variance (ANOVA), Chi-square or Fisher's exact test and Pearson's Correlation assay was used for all data. Results Asymptomatic (AS), mild symptoms (MS) and severe or critical cases (SCS) with COVID-19 were 11 (11/48, 22.9%), 26 (54.2%, 26/48) and 11 cases (11/48, 22.9%), respectively. The mean age of AS group (47.3 years) was lower than SCS group (63.5 years) (P < 0.05). Diabetes mellitus in AS, MS and SCS patients with COVID-19 were 0, 6 and 5 cases, respectively, and there was a significant difference between AS and SCS (P < 0.05). No statistical differences were found in the viral loads of SARS-CoV-2 between AS, MS and SCS groups on admission to hospital and during hospitalization. The concentration of CD 3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), CD3 + CD8 + T cells (P < 0.01), and B cells (P < 0.05) in SCS patients was lower than in AS and MS patients, while the level of IL-5 (P < 0.05), IL-6 (P < 0.05), IL-8 (P < 0.01) and IL-10 (P < 0.01), and TNF-alpha (P < 0.05) was higher. The age was negatively correlated with CD3 + T cells (P < 0.05), CD3 + CD4 + T cells (P < 0.05), and positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05), and IL-10 (P < 0.05). The viral loads were positively correlated with IL-2 (P < 0.001), IL-5 (P < 0.05), IL-6 (P < 0.05) IL-8 (P < 0.05) and IL-10 (P < 0.05), while negatively correlated with CD 3 + T cells (P < 0.05) and CD3 + CD4 + T cells (P < 0.05). Conclusions The viral loads are similar between asymptomatic, mild and severe or critical patients with COVID-19. The severity of COVID-19 may be related to underlying diseases such as diabetes mellitus. Lymphocyte subset and plasma cytokine levels may be as the markers to distinguish severely degrees of disease, and asymptomatic patients may be as an important source of infection for the COVID-19.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Shuo Feng
    Daniel J. Phillips
    Thomas White
    Homesh Sayal
    Parvinder K. Aley
    Sagida Bibi
    Christina Dold
    Michelle Fuskova
    Sarah C. Gilbert
    Ian Hirsch
    Holly E. Humphries
    Brett Jepson
    Elizabeth J. Kelly
    Emma Plested
    Kathryn Shoemaker
    Kelly M. Thomas
    Johan Vekemans
    Tonya L. Villafana
    Teresa Lambe
    Andrew J. Pollard
    Merryn Voysey
    Nature Medicine, 2021, 27 : 2032 - 2040
  • [22] Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
    Marchi, Serena
    Viviani, Simonetta
    Remarque, Edmond J.
    Ruello, Antonella
    Bombardieri, Emilio
    Bollati, Valentina
    Milani, Gregorio P.
    Manenti, Alessandro
    Lapini, Giulia
    Rebuffat, Annunziata
    Montomoli, Emanuele
    Trombetta, Claudia M.
    PLOS ONE, 2021, 16 (07):
  • [23] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
    Feng, Shuo
    Phillips, Daniel J.
    White, Thomas
    Sayal, Homesh
    Aley, Parvinder K.
    Bibi, Sagida
    Dold, Christina
    Fuskova, Michelle
    Gilbert, Sarah C.
    Hirsch, Ian
    Humphries, Holly E.
    Jepson, Brett
    Kelly, Elizabeth J.
    Plested, Emma
    Shoemaker, Kathryn
    Thomas, Kelly M.
    Vekemans, Johan
    Villafana, Tonya L.
    Lambe, Teresa
    Pollard, Andrew J.
    Voysey, Merryn
    NATURE MEDICINE, 2021, 27 (11) : 2032 - +
  • [24] Comparative Analysis of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children
    Li, Jiahui
    Thoon, Koh Cheng
    Chong, Chia Yin
    Maiwald, Matthias
    Kam, Kai-qian
    Nadua, Karen
    Tan, Natalie W. H.
    Yung, Chee Fu
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (08) : 530 - 537
  • [25] Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
    Marchi, Serena
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 309 - 309
  • [26] Asymptomatic SARS-CoV-2 infection
    Ooi, Eng Eong
    Low, Jenny G.
    LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 996 - 998
  • [27] Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility
    Cheng, Hui Mei
    Zhao, Xiahong
    Lim, Wei Shyann
    Tan, Beatrice Jia Min
    Tey, Hong Liang
    PLOS ONE, 2021, 16 (09):
  • [28] Laboratory analysis of symptomatic and asymptomatic pregnant women with SARS-CoV-2 infection
    Fisher, Stephanie A.
    Goldstein, Jeffery A.
    Mithal, Leena B.
    Isaia, Alexandra
    Shanes, Elisheva D.
    Otero, Sebastian
    Miller, Emily S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S515 - S516
  • [29] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    El-Ghitany, Engy Mohamed
    Hashish, Mona H.
    Farghaly, Azza Galal
    Omran, Eman A.
    Osman, Nermin A.
    Fekry, Marwa M.
    TROPICAL MEDICINE AND HEALTH, 2022, 50 (01)
  • [30] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    Engy Mohamed El-Ghitany
    Mona H. Hashish
    Azza Galal Farghaly
    Eman A. Omran
    Nermin A. Osman
    Marwa M. Fekry
    Tropical Medicine and Health, 50